IS4460A - Sýklósporín samsetningar til inntöku um munn - Google Patents

Sýklósporín samsetningar til inntöku um munn

Info

Publication number
IS4460A
IS4460A IS4460A IS4460A IS4460A IS 4460 A IS4460 A IS 4460A IS 4460 A IS4460 A IS 4460A IS 4460 A IS4460 A IS 4460A IS 4460 A IS4460 A IS 4460A
Authority
IS
Iceland
Prior art keywords
oral cyclosporine
cyclosporine formulations
formulations
oral
cyclosporine
Prior art date
Application number
IS4460A
Other languages
English (en)
Inventor
J. Cho Moo
E. Levy Ralph
J. Pouletty Philippe
Floc'h Robert
Merle Christian
Original Assignee
Sangstat Medical Corporation
University Of North Carolina At Chapel Hill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/519,689 external-priority patent/US5834017A/en
Priority claimed from US08/620,021 external-priority patent/US5766629A/en
Priority claimed from US08/622,516 external-priority patent/US5827822A/en
Application filed by Sangstat Medical Corporation, University Of North Carolina At Chapel Hill filed Critical Sangstat Medical Corporation
Publication of IS4460A publication Critical patent/IS4460A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IS4460A 1995-08-25 1997-04-08 Sýklósporín samsetningar til inntöku um munn IS4460A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/519,689 US5834017A (en) 1995-08-25 1995-08-25 Oral cyclopsporin formulations
US08/620,021 US5766629A (en) 1995-08-25 1996-03-21 Oral cyclosporin formulations
US08/622,516 US5827822A (en) 1996-03-25 1996-03-25 Cyclosporin a formulations as nanoparticles
PCT/US1996/012569 WO1997007787A1 (en) 1995-08-25 1996-07-31 Oral cyclosporin formulations

Publications (1)

Publication Number Publication Date
IS4460A true IS4460A (is) 1997-04-08

Family

ID=27414735

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4460A IS4460A (is) 1995-08-25 1997-04-08 Sýklósporín samsetningar til inntöku um munn

Country Status (26)

Country Link
EP (1) EP0789561B1 (is)
JP (1) JP3009742B2 (is)
KR (1) KR100294935B1 (is)
CN (1) CN1164828A (is)
AR (1) AR001985A1 (is)
AT (1) ATE263550T1 (is)
AU (1) AU709548B2 (is)
BG (1) BG62875B1 (is)
BR (1) BR9606603A (is)
CA (1) CA2202887A1 (is)
CZ (1) CZ124897A3 (is)
DE (2) DE789561T1 (is)
ES (1) ES2129381T1 (is)
GE (1) GEP20012547B (is)
HU (1) HUP9801052A3 (is)
IL (1) IL120673A0 (is)
IS (1) IS4460A (is)
MX (1) MX9702809A (is)
NO (1) NO971890D0 (is)
NZ (1) NZ313899A (is)
PL (1) PL319898A1 (is)
RO (1) RO119815B1 (is)
SI (1) SI9620014A (is)
SK (1) SK53697A3 (is)
TW (1) TW460287B (is)
WO (1) WO1997007787A1 (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
CZ301382B6 (cs) * 1997-03-12 2010-02-10 Abbott Laboratories Chad377/Ap6D-2 Hydrofilní binární systémy pro podávání cyklosporinu
AU748334B2 (en) 1997-10-16 2002-05-30 Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with NF-AT3 function
WO2000040219A1 (en) 1998-12-30 2000-07-13 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosporin
US6656504B1 (en) * 1999-09-09 2003-12-02 Elan Pharma International Ltd. Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
PT1435910E (pt) * 2001-10-19 2009-09-07 Isotechnika Inc Novos pré-concentrados de microemulsão de análogos da ciclosporina
WO2008122965A2 (en) * 2007-04-04 2008-10-16 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
EP2061587A1 (en) 2007-04-26 2009-05-27 Sigmoid Pharma Limited Manufacture of multiple minicapsules
US20090130198A1 (en) * 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
EP2464341B1 (en) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
HUE053624T2 (hu) 2014-11-07 2021-07-28 Sublimity Therapeutics Ltd Ciklosporint tartalmazó készítmények
CN104940132B (zh) * 2015-06-05 2018-02-27 河南牧翔动物药业有限公司 一种硫酸小檗碱口服液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
DK0589843T3 (da) * 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
JP3833248B2 (ja) * 1994-11-03 2006-10-11 ノバルティス・アクチエンゲゼルシャフト 簡単な組成及び高い生物有効性を有する経口投与のためのシクロスポリンの新規処方物及びその製造法

Also Published As

Publication number Publication date
CA2202887A1 (en) 1997-03-06
BR9606603A (pt) 1997-09-30
KR970706803A (ko) 1997-12-01
EP0789561B1 (en) 2004-04-07
BG62875B1 (bg) 2000-10-31
DE789561T1 (de) 1999-06-10
BG101443A (en) 1998-03-31
ATE263550T1 (de) 2004-04-15
AU709548B2 (en) 1999-09-02
ES2129381T1 (es) 1999-06-16
CN1164828A (zh) 1997-11-12
AU6644196A (en) 1997-03-19
KR100294935B1 (ko) 2001-07-12
EP0789561A1 (en) 1997-08-20
AR001985A1 (es) 1998-01-07
RO119815B1 (ro) 2005-04-29
TW460287B (en) 2001-10-21
NO971890L (no) 1997-04-24
JPH10509462A (ja) 1998-09-14
HUP9801052A2 (hu) 1998-09-28
HK1001956A1 (en) 1998-07-24
DE69632125T2 (de) 2004-09-16
CZ124897A3 (en) 1997-09-17
SI9620014A (sl) 1998-04-30
NO971890D0 (no) 1997-04-24
HUP9801052A3 (en) 1998-12-28
GEP20012547B (en) 2001-10-25
WO1997007787A1 (en) 1997-03-06
EP0789561A4 (en) 1998-12-02
NZ313899A (en) 2000-03-27
SK53697A3 (en) 1997-10-08
JP3009742B2 (ja) 2000-02-14
DE69632125D1 (de) 2004-05-13
IL120673A0 (en) 1997-08-14
PL319898A1 (en) 1997-09-01
MX9702809A (es) 1998-02-28

Similar Documents

Publication Publication Date Title
IS2184B (is) Lyfjaform með áfangalosun til inntöku um munn
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
NO993096D0 (no) Orale cyklosporinformuleringer
DK1093815T3 (da) Oral 2-methyl-thieno-benzodiazepinformulering
EE9800123A (et) Stabiilsed lüofiliseeritud ravimvormid
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
IS4460A (is) Sýklósporín samsetningar til inntöku um munn
ZA964928B (en) Oral formulations of S(+)-etodolac.
FI951316L (fi) Peroraalinen formulaatio
ITMI951395A0 (it) Formulazioni di f-silicone
ID16781A (id) Formulasi-formulasi farmasi
DK0994697T3 (da) Rapamycinformuleringer til oral indgivelse
EP0837863A4 (en) DISODIUM ALENDRONATE PREPARATIONS
BR9606974A (pt) Composições orais
DE69615586D1 (de) Polyelektrolyte enthaltende zusammensetzungen
ZA96392B (en) Pharmaceutical formulations
GB9509291D0 (en) Formulations
GB9500978D0 (en) Pharmaceutical formulations
ITMI950171A0 (it) Emulsionanti per composizioni cosmetiche
SE9502453D0 (sv) Drug formulations
GB9516584D0 (en) Pharmaceutical formulations
GB9508989D0 (en) Pharmaceutical formulations
GB9503752D0 (en) Pharmaceutical formulations
GB9508144D0 (en) Formulations